BSE demat auction list for settlement number 815 dated February 9, 2026, containing 223 scrips with their respective auction quantities.
Impact
Medium
Severity
Medium
Justification
Routine demat auction list affecting multiple securities across various sectors. Important for settlement obligations but part of regular market operations.
NSE circular notifying listing of further equity shares for ICICI Prudential Life, L&T, MIRC Electronics, Orchasp, RBL Bank, and Wipro effective February 06, 2026.
Impact
Low
Severity
Low
Justification
Routine listing of further equity shares under ESOP and preferential allotment. Standard administrative notification with minimal market impact.
BSE announces securities entering, exiting, and moving within the Short Term Additional Surveillance Measure (ST-ASM) framework effective February 02, 2026.
Impact
Medium
Severity
Medium
Justification
Affects trading conditions for 16+ securities through surveillance framework changes, impacting liquidity and trading costs for specific stocks
NSE circular updating the list of securities under Short-Term Additional Surveillance Measure framework, effective January 16, 2026.
Impact
Medium
Severity
Medium
Justification
Affects trading conditions for 23 securities under ASM framework. One new security added to Stage-I, five securities excluded from ASM. Impacts trading members and investors in these securities.
List of securities and quantities to be auctioned in demat auction settlement number 795 dated January 12, 2026.
Impact
Medium
Severity
Medium
Justification
Demat auction affects specific securities and quantities for settlement purposes. Important for brokers and investors holding these positions but limited to auction participants.
BSE circular listing securities entering, exiting, and moving between stages in the Short Term Additional Surveillance Measure (ST-ASM) framework effective January 08, 2026.
Impact
Medium
Severity
Medium
Justification
Affects trading conditions for specific securities under surveillance. Material impact on listed companies and their investors, but limited to identified scrips. Routine surveillance measure implementation.